Having trouble viewing this email? View in your browser.

20 November 2018

Dear colleagues,

Please find below the latest edition of ESCMID Weekly News.

With kind regards,

ESCMID Executive Office.


Preliminary ECCMID programme released

Start to plan your ECCMID learning journey now! The preliminary programme is now online, outlining the Keynote Lectures, Scientific Symposia, Meet-the-Expert Sessions, Educational Workshops, as well as the Clinical Grand Round. More than 300 speakers from 40 countries in Europe and beyond will contribute to 120 sessions.

› Read more

ECCMID travel grant applications closing soon

Have you submitted your abstract for ECCMID and would like support to get to the conference?

ESCMID Young Scientist Members who have submitted an abstract can also apply for a grant, which covers registration costs, and €500 towards travel costs.

The application for ECCMID 2019 travel grants will end on the 30th of November 2018.

› Read more

ESCMID President honored by Spanish Ministry of Health

Last Friday, during the celebration of the European Antibiotic Awareness Day in Spain, Jesus Rodríguez-Baño received the Research Award of the Spanish Plan Against Antimicrobial Resistance from the Ministry of Health.

› Read more

CMI highlight: Effective chemical virus inactivation of patient serum compatible with accurate serodiagnosis of infections

Remy et al aimed to assess the accuracy of 19 serological tests after chemical (Triton X-100 1%, 0.1%, and 0.1%) or thermal (60°C, 60 minutes) inactivation of patient serum samples containing herpes simplex virus-1 (HSV-1).

Serological measurements showed good agreement between controls and samples treated with Triton X-100 0.1% and 1%, with an estimated bias of -0.6±9.2% (n=258) and -0.1±18.6% (n=174), respectively. Discordant qualitative results were rare. Conversely, heat inactivation alone, and combined with Triton X-100 0.1% triggered a bias of 17.5±66.4% (n=200) and 37.9±79.8% (n=160), respectively. Triton X-100 1% completely inactivated HSV-1 in 1% and 90% serum while Triton X-100 0.1% failed to do so in 90% serum.

In conclusion, the results indicate that unlike heat inactivation, Triton X-100 1% enabled accurate serological testing and completely inactivated HSV-1 in serum, allowing for a simple and safe method to routinely diagnose high-risk patients.

› Read more

One week left to submit comments on the guideline manuscripts currently in public consultation phase

Last week to submit comments on the manuscripts of two upcoming guidelines! The deadlines are:

› Read more

LEASH survey results published

ESGAP’s survey results on legal frameworks for antimicrobial stewardships in hospitals is now published. Download the publication until December 28th on authors.elsevier.com

› Read more
ESCMID Executive Office
P.O. Box 214
4010 Basel
Phone +41 61 5080 173
Visit us on LinkedIn Visit us on YouTube
The ESCMID Newsletter is issued on behalf of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) by the ESCMID Executive Office. It contains announcements of ESCMID-related matters and other information of interest to professionals in the infection field.

Tip: To ensure that you receive the ESCMID newsletter in your inbox, add newsletter@escmid.org to your email program’s address book.

You have received this email as a contact of ESCMID or one of its affiliated societies. You can unsubscribe or change your newsletter subscriptions here.